Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuroendocrine (NE) Tumors”

17 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 17 results

Not applicableNot Yet RecruitingNCT07780539
What this trial is testing

Real-World Study of the Safety and Efficacy of Surufatinib in the Treatment of Neuroendocrine Tumors

Who this might be right for
Neuroendocrine (NE) Tumors
Yefeng 60
Testing effectiveness (Phase 2)Looking for participantsNCT07284589
What this trial is testing

Ultralow Dose PET Imaging of SSTR2 Radiotracer Uptake

Who this might be right for
Healthy (Controls)Healthy VolunteersNeuroendocrine (NE) Tumors
Akiva Mintz 200
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07640737
What this trial is testing

AUR103 Calcium in Advanced Neuroendocrine Tumours (BHARAT-3 Study)

Who this might be right for
Neuroendocrine (NE) TumorsAdvanced NET of GI Origin
Aurigene Discovery Technologies Limited 30
Not applicableStudy completedNCT06779708
What this trial is testing

The Role of Intraoperative Hepatic Ultrasonography in Gastrointestinal or Pancreatic Neuroendocrine Tumor

Who this might be right for
Neuroendocrine (NE) TumorsLiver Metastasis
Istituto Clinico Humanitas 51
Testing effectiveness (Phase 2)Ended earlyNCT07012330
What this trial is testing

Comparing 177Lu-Dotatate/Capecitabine Combination Treatment With 177Lu-Dotatate in Neuroendocrine Tumor Patients

Who this might be right for
Neuroendocrine (NE) Tumors
Erasmus Medical Center 111
Testing effectiveness (Phase 2)WithdrawnNCT02030184
What this trial is testing

Phase I/II Trial of Rhenium 188-P2045 in Small Cell Lung Cancer and Other Advanced Neuroendocrine Carcinomas

Who this might be right for
Small Cell Lung Cancer (SCLC)Neuroendocrine (NE) TumorsLarge Cell Neuroendocrine (NE) Tumors
University of Maryland, Baltimore
Not applicableLooking for participantsNCT06787014
What this trial is testing

Resection of the Primary Tumor vs. Systemic Treatment Alone for Patients With Small Intestinal Neuroendocrine Tumors and Unresectable Metastases: a Europe-wide Study

Who this might be right for
Neuroendocrine (NE) TumorsMetastasisBowel Obstruction
Insel Gruppe AG, University Hospital Bern 3,200
Not applicableNot Yet RecruitingNCT07258810
What this trial is testing

Evaluation of Tolerance and Quality of Life in Patients With Neuroendocrine Tumors Treated With Oral Anti-Tumor Drugs Within a Therapeutic Education Program

Who this might be right for
Neuroendocrine (NE) TumorsOral Anti-Tumor DrugsTherapeutic Education Program
Hospices Civils de Lyon 100
Not applicableLooking for participantsNCT06773624
What this trial is testing

Use of 68Ga-DOTATOC PET/CT-enterography for Detection of the Primary Lesion in Neuroendocrine Tumors of the Small Bowel

Who this might be right for
Small Bowel NeoplasiaNeuroendocrine (NE) Tumors
European Institute of Oncology 18
Testing effectiveness (Phase 2)Ended earlyNCT03211988
What this trial is testing

Entinostat Neuroendocrine (NE) Tumor

Who this might be right for
Neuroendocrine Tumors
Antonio Fojo 5
Not applicableNot Yet RecruitingNCT07471425
What this trial is testing

Survival Without Persistent Limiting Toxicity: Real Life Prospective Cohort of Advanced Neuroendocrine Tumor

Who this might be right for
Neuroendocrine (NE) Tumors
Gustave Roussy, Cancer Campus, Grand Paris 1,100
Very early researchWithdrawnNCT07052760
What this trial is testing

Imaging of Solid Tumors Using DLL3 SPECT

Who this might be right for
Solid Tumor CancerCastration Resistant Prostate CancerCastration Resistant Prostate Cancer (CRPC)+1 more
Thomas Hope
Not applicableLooking for participantsNCT06717243
What this trial is testing

Genomic and Methylation Markers in SCLC and LCNEC for Chemo-Immunotherapy Resistance Prediction (STRATUS)

Who this might be right for
Small Cell Lung CancerLarge Cell Neuroendocrine (NE) TumorsTreatment Failure+3 more
Oncology Center of Biochemical Education And Research 111
Not applicableLooking for participantsNCT06981455
What this trial is testing

Life Following Excision of Neuroendocrine Tumors

Who this might be right for
Neuroendocrine (NE) TumorsNeuroendocrine Tumor GEP Grade 1-3
Sunnybrook Health Sciences Centre 246
Early research (Phase 1)Looking for participantsNCT06062745
What this trial is testing

Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT

Who this might be right for
Advanced Prostate CancerMetastatic Prostate CancerMetastatic Prostate Neuroendocrine Carcinoma
Brigham and Women's Hospital 30
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07542158
What this trial is testing

Ultralow Dose PET Imaging of 18F-FDOPA

Who this might be right for
Heathy VolunteerParkinsonian SyndromesNeuroendocrine (NE) Tumors+1 more
Akiva Mintz 200
Not applicableLooking for participantsNCT07121998
What this trial is testing

Study of Acquired Resistance to Alkylator Chemotherapy in Endocrine Neoplasms

Who this might be right for
Neuroendocrine (NE) TumorsEndocrine Cancer
Uppsala University 94